...
首页> 外文期刊>Acta Cytologica: The Journal of Clinical Cytology and Cytopathology >Comment on the Paper by Safi Oz et al. Entitled 'Evaluation of Micronuclei, Nuclear Anomalies and the Nuclear/Cytoplasmic Ratio of Exfoliated Cervical Epithelial Cells in Genital Candidiasis'.
【24h】

Comment on the Paper by Safi Oz et al. Entitled 'Evaluation of Micronuclei, Nuclear Anomalies and the Nuclear/Cytoplasmic Ratio of Exfoliated Cervical Epithelial Cells in Genital Candidiasis'.

机译:Safi Oz等人对该论文发表评论。题为“生殖器念珠菌病中脱落的宫颈上皮细胞的微核,核异常和核/细胞质比率的评估”。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

One major current challenge facing companies producing injectable drugs contained in glass vials is the phenomenon of delamination that results in drug contamination. Glass delamination is defined as degradation of surface glass, as from a vial, that produces glass flakes. Contamination of injectable drugs due to glass delamination is a fact of life. Normally, this type of contamination does not involve immediate severe signs, but rather accumulative damage to tissues in the long run. Recently, the U.S. Food and Drug Administration allowed the filtration as means of removing particles. The vial adapter is a needle-free product from West Pharmaceuticals Services that provides a simple and cost-effective solution for the safe and rapid transfer reconstitution of drugs between vials and syringes. One variant of the vial adapter is integrated with a filter to address various types of particles. In the present study, the performance of the filter-integrated vial adapter is evaluated with respect to glass delamination particles. Silica particles of 0.5-10 μm are used to emulate glass delamination particles. High-filtration efficiency is demonstrated according to the severest criteria stated by the British Pharmacopoeia that allows up to 100 particles smaller than 5 μm for every 1 mL liquid of a large-volume parenteral. The study was conducted using environmental scanning electron microscopy and statistical analysis.
机译:生产玻璃瓶中可注射药物的公司当前面临的主要挑战之一是分层现象,这会导致药物污染。玻璃分层定义为表面玻璃的降解,例如从玻璃瓶中产生玻璃片的降解。由于玻璃分层而造成的可注射药物污染是生活中的事实。通常,从长远来看,这种类型的污染并不涉及立即的严重征兆,而是对组织的累积损害。最近,美国食品和药物管理局允许过滤作为去除颗粒的手段。样品瓶适配器是West Pharmaceuticals Services的无针产品,为在样品瓶和注射器之间安全快速地重新配制药物提供了一种简单且经济高效的解决方案。样品瓶适配器的一种变型与过滤器集成在一起,可处理各种类型的颗粒。在本研究中,针对玻璃分层颗粒评估了集成过滤器的样品瓶适配器的性能。 0.5-10μm的二氧化硅颗粒用于模拟玻璃分层颗粒。根据英国药典规定的最严格标准,证明了高过滤效率,每1毫升大剂量肠胃外液体最多允许100个小于5μm的颗粒。该研究使用环境扫描电子显微镜和统计分析进行。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号